William W. Wyman - Jul 7, 2022 Form 3 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Director
Signature
/s/ Jason L. Langford, Attorney-in-Fact for William W. Wyman
Stock symbol
PMN
Transactions as of
Jul 7, 2022
Transactions value $
$0
Form type
3
Date filed
7/7/2022, 07:21 PM
Next filing
Oct 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PMN Common Shares 62.9K Jul 7, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PMN Option (right to buy) Jul 7, 2022 Common Shares 3.33K $4.80 Direct F1, F2
holding PMN Option (right to buy) Jul 7, 2022 Common Shares 4.17K $4.89 Direct F1, F3
holding PMN Option (right to buy) Jul 7, 2022 Common Shares 4.17K $9.60 Direct F1, F4
holding PMN Option (right to buy) Jul 7, 2022 Common Shares 8.33K $10.20 Direct F1, F5
holding PMN Warrants (right to buy) Jul 7, 2022 Common Shares 2.78K $28.80 Direct F1
holding PMN Warrants (right to buy) Jul 7, 2022 Common Shares 4.55K $12.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion or exercise price is in Canadian dollars.
F2 The options immediately vested.
F3 The option agreement provides that 25% of the options vest immediately, with the remainder vesting ratably over the next three quarters. The option was granted on October 7, 2015.
F4 The option agreement provides that 25% of the options vest immediately, with the remainder vesting ratably over the next three quarters. The option was granted on September 19, 2016.
F5 The option agreement provides that 25% of the options vest immediately, with the remainder vesting ratably over the next three quarters. The option was granted on March 30, 2021.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney